| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115368 Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides |
| 10/03/2006 | US7115367 Method for the specific detection and identification of retroviral nucleic acids/retroviruses in a specimen |
| 10/03/2006 | US7115366 Eubacterial tmRNA sequences and uses thereof |
| 10/03/2006 | US7115364 Arrays of nucleic acid probes on biological chips |
| 10/03/2006 | US7115363 Retrovirus capable of causing AIDS, means and methods for detecting it in vitro |
| 10/03/2006 | US7115229 Detection of preferential biopolymers in sample; obtain sample, incubate with probes, detect signal, monitor and record pattern |
| 10/03/2006 | CA2135039C Solid-phase synthesis of oligoribonucleotides |
| 09/28/2006 | WO2006102652A2 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms |
| 09/28/2006 | WO2006102264A1 Thermal reaction device and method for using the same |
| 09/28/2006 | WO2006102095A2 Framework-shuffling of antibodies |
| 09/28/2006 | WO2006101911A1 Selective inhibitors of translesion dna replication |
| 09/28/2006 | WO2006101841A2 Seneca valley virus based compositions and methods for treating disease |
| 09/28/2006 | WO2006101810A2 Theileria parva dna vaccines |
| 09/28/2006 | WO2006101584A2 Cellulases, nucleic acids encoding them and methods for making and using them |
| 09/28/2006 | WO2006099706A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 09/28/2006 | WO2006058046A3 Apparatus and system having dry gene silencing pools |
| 09/28/2006 | WO2006051545A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/28/2006 | WO2006012366A3 Methods for making and using recombinant bacillus thuringiensis spores |
| 09/28/2006 | WO2006009629A3 Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same |
| 09/28/2006 | WO2006004611A3 Separation of nucleic acid |
| 09/28/2006 | WO2005074650A3 Modified human four helical bundle polypeptides and their uses |
| 09/28/2006 | WO2005059109A3 Molecular signature of the pten tumor suppressor |
| 09/28/2006 | WO2005043114A3 Oligonucleotide probe sets and uses thereof |
| 09/28/2006 | WO2005034732A3 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 09/28/2006 | WO2005021776A3 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
| 09/28/2006 | WO2004089305A3 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same |
| 09/28/2006 | WO2004067765A3 Organism fingerprinting using nicking agents |
| 09/28/2006 | WO2003076578A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/28/2006 | WO2003057841A3 Remote homologues and kinases and methods of detection |
| 09/28/2006 | WO2003028531A3 Detection of tumor rna in plasma and serum |
| 09/28/2006 | US20060218676 Compositions and method for modulation of plant cell division |
| 09/28/2006 | US20060218673 Gene silencing |
| 09/28/2006 | US20060218672 Method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant |
| 09/28/2006 | US20060218671 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 09/28/2006 | US20060218670 Compositions and methods for production of sialylated glyoproteins in plants |
| 09/28/2006 | US20060218667 Plant-produced recombinant aprotinin and aprotinin variants |
| 09/28/2006 | US20060218662 Introducing into a plant cell an expression cassette comprising a promoter operably linked to a heterologous nucleotide; transcription, gene expression; regenerating a transformed plant from plant cell; transgenic seeds; herbicide or pest resistance |
| 09/28/2006 | US20060218661 Novel sesquiterpene synthase gene and protein |
| 09/28/2006 | US20060218659 L450 polypeptide and nucleic acid encoding it; transgenic plant |
| 09/28/2006 | US20060218653 determining that a single nucleotide point mutation in the fourth exon of the nucleic acid sequence encoding dog CLN5 results in the production of a variant soluble lysosomal glycoprotein, specifically CLN5, which exhibits aberrant functional activity |
| 09/28/2006 | US20060217546 3-Deoxypentopyranosyl nucleic acid, its production and its use |
| 09/28/2006 | US20060217545 Sequence-determined DNA fragments encoding SRF-type transcription factor proteins |
| 09/28/2006 | US20060217544 Sequence-determined DNA fragments encoding thioredoxin proteins |
| 09/28/2006 | US20060217543 Polynucleotide of given sequence, encoding polypeptide; use in controlling gene expression or as tools for genetic mapping |
| 09/28/2006 | US20060217542 use in genetic engineering of plants, host cells |
| 09/28/2006 | US20060217541 Sequence-determined DNA fragments encoding glutamine amidotransferase proteins |
| 09/28/2006 | US20060217540 Fragments of a plant genome; controlling the expression of a gene; tools for genetic mapping; recognizing or isolating identical or related DNA fragments; identification of a particular individual organism; clustering of a group of organisms with a common trait |
| 09/28/2006 | US20060217539 Sequence-determined DNA fragments encoding AP2 domain proteins |
| 09/28/2006 | US20060217535 Hemipteran muscarinic receptor |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217360 Tubulysin biosynthesis gene |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060217339 Breast cancer, prostate cancer, brain cancer, head and neck cancer, myeloma, melanoma, leukemia and lymphoma; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 09/28/2006 | US20060217338 Influenza nucleic acids, polypeptides, and uses thereof |
| 09/28/2006 | US20060217337 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217336 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 09/28/2006 | US20060217335 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217334 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217333 Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function |
| 09/28/2006 | US20060217331 Chemically modified double stranded nucleic acid molecules that mediate RNA interference |
| 09/28/2006 | US20060217330 Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs |
| 09/28/2006 | US20060217328 Derivatized with a glycerol linker, 2'-deoxy-7-deazaguanosine and arabinoguanosine; immunomer is self-complementary; anticarcinogenic, antiinflammatory, antiallergen, antihistamine, and bronchodilator agents; asthma, skin disorders |
| 09/28/2006 | US20060217326 Group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof |
| 09/28/2006 | US20060217298 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 09/28/2006 | US20060216823 Method for obtaining an enriched population of siRNA-expressing cells |
| 09/28/2006 | US20060216809 cGMP-binding, cGMP-specific phosphodiesterase materials and methods |
| 09/28/2006 | US20060216793 Culturing Bacillus strain with purified nucleic acid segment having coding region encoding enzymatically active hyaluronan synthase to produce hyaluronic acid; genetic engineering |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216787 Modified Shine-Dalgarno sequences and methods of uses thereof |
| 09/28/2006 | US20060216786 Feline interferon-alpha proteins |
| 09/28/2006 | US20060216785 Genetic engineering; fusion protein; comprising a recombinant vector containing a nucleic acid sequence encoding a ubiquitin like molecule (UBL) molecule selected from the group of SUMO, RUB, HUB, URM1, and ISG15 operably linked to a promoter suitable for expression in the desired host cell |
| 09/28/2006 | US20060216784 Process for production of polypeptides |
| 09/28/2006 | US20060216783 Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host |
| 09/28/2006 | US20060216782 Methods for expression and purification of immunotoxins |
| 09/28/2006 | US20060216776 Screening assay for agents that alter target of rapamycin activity |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216750 New lipid binding protein 1 |
| 09/28/2006 | US20060216749 Chimeric gaba receptor |
| 09/28/2006 | US20060216748 Genes differentially expressed in breast cancer |
| 09/28/2006 | US20060216747 first nucleotide sequence complementary to a target RNA sequence or a portion thereof, and a second sequence chemically modified so that it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; pharmaceutical use such as viricide |
| 09/28/2006 | US20060216746 Novel protein and DNA thereof |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216740 Methods for the electronic, homogeneous assembly and fabrication of devices |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216736 Labeling reagent |
| 09/28/2006 | US20060216733 Eubacterial tmRNA sequences and uses thereof |
| 09/28/2006 | US20060216730 Novel human protein kinases and protein kinase-like enzymes |
| 09/28/2006 | US20060216727 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/28/2006 | US20060216723 High through-put detection of pathogenic yeasts in the genus trichosporon |
| 09/28/2006 | US20060216722 Glomerular expression profiling |
| 09/28/2006 | US20060216719 Novel short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use |
| 09/28/2006 | US20060216717 Novel human polynucleotides and the polypeptides encoded thereby |
| 09/28/2006 | US20060216712 Hybridization, immobilization; genotypes |
| 09/28/2006 | US20060216711 Variants of cytochrome c and methods of diagnosis of thrombocytopenia |
| 09/28/2006 | US20060216710 Screening for compound that activates or inhibits activity of Aster Associated Protein; over-expression disrupts mitotic spindle assembly and leads to aberrant and abortive mitosis |
| 09/28/2006 | US20060216709 Midkine-like protein |
| 09/28/2006 | US20060216708 Method for lowering both sequence variations and increase of base lines effects in diagnostic hybridisation assay, assay for performing such a method and probe for use in the assay |
| 09/28/2006 | US20060216706 Proteins associated with cell growth, differentiation, and death |
| 09/28/2006 | US20060216703 Extraction and concentration method |